









第三代 堀江教授業績（2）循環器内科 英文雑誌 2003～2014
英文雑誌 
【２０１４】 
 Hasegawa K, Ohno S, Ashihara T, Itoh H, Ding WG, Toyoda F, Makiyama T, Aoki H, 
Nakamura Y, Delisle BP, Matsuura H, Horie M. A novel KCNQ1 missense mutation 
identified in a patient with juvenile-onset atrial fibrillation causes constitutively 
open IKs channels. Heart Rhythm. 11(1): 67-75, 2014. 
 Hayashi H, Miyamoto A, Kawaguchi T, Naiki N, Xue J, Murakami Y, Horie M. P 
Pulmonale and the Development of Atrial Fibrillation. Circulation Journal 78(2): 
329-37, 2014. 
 Kato K, Makiyama T, Wu J, Ding WG, Kimura H, Naiki Nobu, Ohno Seiko, Itoh H, 
Nakanishi T, Matsuura H, Horie M. Cardiac Channelopathies Associated With 
Infantile Fatal Ventricular Arrhythmias, From The Cradle to The Bench. J 
Cardiovasc Electrophysiol 25(1): 66-73, 2014. 
 Wang Q, Ohno S, Ding WG, Fukuyama M, Miyamoto A, Itoh H, Makiyama T, Wu J, 
Bai J, Hasegawa K, Shinohara T, Takahashi N, Shimizu A, Matsuura H, Horie M. 
Gain-of-Function KCNH2 Mutations in Patients with Brugada Syndrome. J 
Cardiovasc Electrophysiol. 25(5):522-30, 2014 
 Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, Ushinohama H, 
Makita N, Horie M. Exon-3 Deletion of RYR2 Encoding Cardiac Ryanodine 
Receptor is Associated with Left Ventricular Non-Compaction. Europace 
0(0)1-9,2014 
 Kokunai Y, Nakata T, Furuta M, Sakata S, Kimura H, Aiba T, Yoshinaga M, Osaki 
Y, Nakamori M, Itoh H, Sato T, Kubota T, Kadota K, Shindo K, Mochizuki H, 
Shimizu W, Horie M, Okamura Y, Ohno K, Takahashi MP. A Kir3.4 mutation causes 
Andersen – Tawil syndrome by an inhibitory effect on Kir2.1. 
Neurology.82(12):1058-64, 2104 
 Sakata S, Kurata Y, Li P, Notsu T, Morikawa K, Miake J, Higaki K, Yamamoto Y, 
Yoshida A, Shirayoshi Y, Yamamoto K, Horie M, Ninomiya H, Kanzaki S, Hisatome 
I. Instability of KCNE1-D85N that causes long QT syndrome: stabilization by 
verapamil. PACE (in press)  
 Zhou J, Ding WG, Makiyama T, Miyamoto A, Matsumoto Y , Kimura H, Tarutani Y, 
Zhao J, Wu J, Zang WJ, Matsuura H, Horie M. A Novel HCN4 Mutation, G1097W, 
is associated with atrioventricular block. Circulation Journal.78(4):938-42, 2014 
 Hayashi H, Kawaguchi T, Horie M. Effect of Flecainide on T-wave Alternans in 
Andersen-Tawil Syndrome. Annals of Noninvasive Electrocardiology (in press) 
 Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, 
Nakatsuji H, Watanabe H, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie 
M, Sobue G. Brugada syndrome in spinal and bulbar muscular atrophy (SBMA). 
Neurology 82(20):1813-21,2014 
 Hasegawa K, Ohno S, Kimura H, Itoh H, Makiyama T, Yoshida Y, Horie M. Mosaic 
KCNJ2 Mutation in Andersen-Tawil syndrome: Targeted Deep Sequencing is 
Useful for the Detection of Mosaicism. Clinical Genetics (in press)  
 Hisamatsu T, Miura K, Ohkubo T, Yamamoto T, Fujiyoshi A, Miyagawa N, Kadota 
A, Takashima N, Okuda N, Yoshita K, Kita Y, Murakami Y, Nakamura Y, Okamura 
T, Horie M. A high dietary long-chain n-3 fatty acids intake attenuates the effect of 
a high resting heart rate on the risk of cardiovascular mortality: A 24-year 
follow-up of the Japanese general population. Journal of 
Cardiology.S0914-5087(14)00023-9, 2014 
 Katsuumi G, Shimizu W, Watanabe H, Noda T, Nogami A, Ohkubo K, Makiyama T, 
Takehara N, Kawamura Y, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe 
M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Makita N, 
Minamino T. Efficacy of bepridil to prevent ventricular fibrillation in severe form of 
early repolarization syndrome. International journal of cardiology ;172(2):519-22, 
2014.  
 Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, 
Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, 
Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi 
O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, 
Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara 
H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; on behalf of the 
CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Late Adverse Events 
After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent: Long-Term 
(5-7 Years) Follow-Up of the Coronary Revascularization Demonstrating Outcome 
Study-Kyoto Registry Cohort-2. Circ Cardiovasc Interv. 7(2):168-79,2014 
 Wu J, Naiki N, Ding WG, Ohno S, Kato K, Zang WJ, Delisle BP, Matsuura H, Horie 
M. A molecular mechanism for adrenergic-induced long QT Syndrome. J Am Coll 
Cardiol.63(8)819-27,2014 
 Yoshinaga M, Kucho Y, Sarantuya J, Ninomiya Y, Horigome H, Ushinohama H, 
Shimizu W, Horie M. Genetic characteristics of children and adolescents with long 
QT syndrome diagnosed by school-based electrocardiographic screening programs. 
Circulation Arrhythmia and Electrophysiol 7: 107-12, 2014. 
 Bartos DC, Giudicessi JR, Tester DJ, Ackerman MJ, Ohno S, Horie M, Gollob MH, 
Burgess DE, Delisle BP. A KCNQ1 Mutation Contributes to the Concealed Type 1 
Long QT Phenotype by Limiting the Kv7.1 Channel Conformational Changes 
Associated with PKA Phosphorylation. Heart Rhythm 11(3): 459-68, 2014. 
 Fukuyama M, Ohno S, Wang Q, Shirayama T, Itoh H, Horie M. Nonsense-mediated 
mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada 
syndrome. Heart Rhythm 11(4):629-34, 2014. 
 Fukuyama M, Qi Wang, Kato K, Ohno S, Wei-Guang Ding, Toyoda F, Itoh H, 
Kimura H, Makiyama T, Ito M, Matsuura H, Horie M. Long QT syndrome Type8: 
novel CACNA1C mutations causing QT prolongation and variant phenotypes. 
Europace 0(0)1-10,2014. 
 Abe Y, Sumitomo N, Okuma H, Nakamura T, Fukuhara J, Ichikawa R, Matsumura 
M, Miyashita M, Kamiyama H, Ayusawa M, Watanabe M, Joo K, Makita N, Horie 
M. Successful control of life-threatening polymorphic ventricular tachycardia by 
radiofrequency catheter ablation in an infant. Heart Vessels 29(3):422-6, 2014. 
 Hasegawa K, Ohno S, Itoh H, Makiyama T, Aiba T, Nakano Y, Shimizu W, 
Matsuura H, Horie M. A rare KCNE1 polymorphism, D85N, as a genetic modifier of 
long QT syndrome. Journal of Arrhythmia 30(3):161-166,2014 
 Nakatsuma k, Shiomi H, Watanabe H, Morimoto T, Taniguchi T, Toyota T, 
Furukawa Y, Nakagawa Y, Horie M, Kimura T, on behalf of the CREDO-Kyoto AMI 
investigators.Comparison of Long-term Mortality After Acute Myocardial 
Infarction Treated by Percutaneous Coronary Intervention in Patients Living Alone 
versus Not Living Alone at the Time of Hospitalizatio(in press) 
 Goto K, Nakai K, Shizuta S, Morimoto T, Shiomi H, Natsuaki M, Yahata M, Ota C, 
Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T, 
Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, 
Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, 
Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, 
CREDO-Kyoto Registry Cohort-2 Investigators. Anticoagulant and Antiplatelet 
Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary 
Intervention The American Journal of Cardiology 114(1) 70-78, 2014.  
 Fujii K, Ozeki Y, Okayasu H, Takano Y, Shinozaki T, Hori H, Orui M, Horie M, 
Kunugi H, Shimoda K. QT Is Longer in Drug-Free Patients with Schizophrenia 
Compared with Age-Matched Healthy Subjects. PLoS One 9(6):e98555.1-6,2014 
 Watanabe E, Tanabe T, Osaka M, Chishaki A, Takase B, Niwano S, Watanabe I, 
Sugi K, Katoh T, Takayanagi K, Mawatari K, Horie M, Okumura K, Inoue H, 
Atarashi H, Yamaguchi I, Nagasawa S, Moroe K, Kodama I, Sugimoto T, Aizawa Y. 
Sudden cardiac arrest recorded during Holter monitoring: Prevalence, antecedent 
electrical events, and outcomes. Heart Rhythm S1547-5271(14)00498-6,2014 
 
【２０１３】 
 Villafane J, Atallah J, Gollob MH, Maury P, Wolpert C, Gebauer R, Watanabe H, 
Horie M, Anttonen O, Kannankeril P, Faulknier B, Bleiz J, Makiyama T, Hamilton 
R, Young M-L. Long Term Follow-up of a Pediatric Cohort with Short QT Syndrome. 
J Am Coll Cardiol. 61(11): 1183-91, 2013.  
 Wu J, Ding WG, Zhao J, Zang WJ, Matsuura H, Horie M. Irbesartan-mediated AT1 
receptor blockade attenuates hyposmostic-induced enhancement of IKs current and 
prevents shortening of action potential duration in atrial myocytes. the Journal of 
the Renin-Angiotensin-Aldosterone System. 0(0)1-7,2013 
 Nakano Y, Chayama K, Ochi H, Toshisige M, Hayashida Y, Miki D, Hayes C. N, 
Suzuki H, TokuyamaT, Oda N, Suenari K, Uchimura-MakitaY, KajiharaK, Sairaku 
A, Motoda C, Fujiwara M, WatanabeY, YoshidaY, Ohkubo K, Watanabe I, Nogami A, 
Hasegawa K, Watanabe H, Endo N, Aiba T, Shimizu W, Ono S, Horie M, Arihiro K, 
Tashiro S, Makita N, Kihara Y. A nonsynonymous polymorphism in Semaphorin 3A 
as a risk factor for human unexplained cardiac arrest with documented ventricular 
fibrillation. PLOS Genetics 9(4): e1003364, 2013. 
 Wang Q, Ohno S, Kato K, Fukuyama M, Makiyama T, Kimura H, Naiki N, 
Kawamura M, Hayashi H, Horie M. Genetic Screening of KCNJ8 in Japanese 
Patients with J-wave Syndromes or Idiopathic Ventricular Fibrillation. Journal of 
Arrhythmia 29: 261-264, 2013.  
 Ohno S, Nagaoka I, Fukuyama M, Kimura H, Itoh H, Makiyama T, Shimizu A, 
Horie M. Age-dependent clinical and genetic characteristics in Japanese patients 
with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation 
Journal 77(6): 1534-1542, 2013. 
 Duchatelet S, Crotti L, Peat R, Denjoy I, Itoh H, Berthet M, Ohno S, Fressart V, 
Monti C, Crocamo C, Pedrazzini M, Dagradi F, Vicentini A, Klug D, Brink P, Goosen 
A, Heikki S, Toivonen L, Lahtinen A, Kontula K, Shimizu W, Horie M, George Jr. 
AL, Tregouet DA, Guicheney P, Schwartz PJ. Identification of a KCNQ1 
polymorphism acting as a protective modifier against arrhythmic risk in long QT 
syndrome. Circulation Cardiovasc Genet 6(4): 354-61, 2013. 
 Takagi M, Aonuma K, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M, FHRS. The 
prognostic value of early repolarization (J wave) and ST- segment morphology after 
J wave in Brugada syndrome: Multicenter study in Japan. Heart Rhythm 10(4): 
533-539, 2013. 
 Dochi K, Watanabe H, Kawamura M, Miyamoto A, Ozawa T, Nakazawa Y, Ashihara 
T, Ohno S, Hayashi H, Ito M, Sakazaki H, Kawata H, Ushinohama H, Kaszynski 
RH, Minamino T, Sumitomo N, Shimizu W, Horie M. Flecainide reduces ventricular 
arrhythmias via different actions from β -blockers in catecholaminergic 
polymorphic ventricular tachycardia. Journal of Arrhythmia 29: 255-260, 2013. 
 Fukuyama M, Ohno S, Wang Q, Kimura H, Makiyama T, Itoh H, Ito M, Horie M. 
L-type calcium channel mutations in Japanese patients with inherited arrhythmias. 
Circulation Journal 77(7): 1799-1806, 2013. 
 Kawamura M, Ohno S, Naiki N, Nagaoka I, Dohchi K, Wang Q, Hasegawa K, 
Kimura H, Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, 
Ushinohama H, Oyama K, Murakoshi N, Aonuma K, Horigome H, Honda T, 
Yoshinaga M, Ito M, Horie M. Genetic background of catecholaminergic 
polymorphic ventricular tachycardia in Japan. Circulation Journal 77(7): 
1705-1713, 2013. 
 Hisamatsu T, Ohkubo T, Miura K, Yamamoto T, Fujiyoshi A, Miyagawa A, Kadota A, 
Takashima N, Nagasawa S, Kita Y, Murakami Y, Okayama A, Horie M, Okamura T, 
Ueshima H. The Association between J-point elevation and death from coronary 
heart disease: a 15-year follow-up of the NIPPON DATA90. Circulation Journal 
77(5): 1260-1266, 2013. 
 Aizawa Y, Chinushi M, Hasegawa K, Naiki N, Horie M, Kaneko Y, Kurabayashi M, 
Ito S, Imaizumi T, Aizawa Y, Takatsuki S, Joo K, Sato M, Ebe K, Hosaka Y, 
Haissaguerre M, Fukuda K. Electrical storm in idiopathic ventricular fibrillation is 
associated with early repolarization. J Am Coll Cardiol. 62(11):1015-1019, 2013. 
 Hisamatsu T, Miura K, Ohkubo T, Yamamoto T, Fujiyoshi A, Miyagawa N, Kadota 
A, Takashima N, Okuda N, Matsumura Y, Yoshita K, Kita Y, Murakami Y, 
Okamura T, Horie M, Okayama A, Ueshima H for the NIPPON DATA80 Research 
Group. Interaction of Dietary n-3 Fatty Acids and J-point Elevation on Cardiac 
Mortality Risk in Japanese Men: A 24-Year Follow-Up of NIPPON DATA80. Heart 
99(14): 1024-1029, 2013. 
 Watanabe H, van der Werf C, Roses-Noguer F, Adler A, Sumitomo N, Veltmann C, 
Rosso R, Bhuiyan ZA, Bikker H, Kannankeril PJ, Horie M, Minamino T, Viskin S, 
Knollmann BC, Till J, Wilde AA. Effects of flecainide on exercise-induced 
ventricular arrhythmias and recurrences in genotype-negative patients with 
catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 10: 
542-547, 2013.  
 Horie M, Ohno S. Genetic basis of Brugada syndrome. Journal of Arrhythmia 29: 
71–76, 2013. 
 Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, 
Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T. Three-year outcome 
after percutaneous coronary intervention and coronary artery bypass grafting in 
patients with triple vessel coronary artery disease: observations from the 
CREDO-Kyoto PCI/CABG registry cohort-2. EuroIntervention 9(4):437-45, 2013. 
 Morikami Y, Natsuaki M, Morimoto T, Ono K, Nakagawa Y, Furukawa Y, Sakata R, 
Aota M, Okada Y, Onoe M, Kawasuji M, Koshiji T, Nakajima H, Nishizawa J, 
Yamanaka K, Yamamoto H, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 
investigators. Impact of polyvascular disease on clinical outcomes in patients 
undergoing coronary revascularization: An observation from the CREDO-Kyoto 
Registry Cohort-2. Atherosclerosis 228(2): 426-431, 2013. 
 Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, Hattori T, 
Ohno S, Kita T, Horie M, Yamanaka S, Kimura T. Ultrastructural maturation of 
human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. 
Circ J. 77(5): 1307-14, 2013. 
 Nakae I, Hayashi H, Mitsunami K, Horie M. Clinical significance of lung iodine-123 
metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases. 
Ann Nucl Med. 27(8): 737–747, 2013. 
 Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, 
Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, 
Antzelevitch C, Bartkowiak S, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen 
R, Tfelt-Hansen J, Olesen MS, Kääb S, Beckmann BM, Weeke P, Watanabe H, Endo 
N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, 
Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel 
R, Coronel R, Boukens BJ, Bézieau S, Charpentier E, Chatel S, Despres A, Gros F, 
Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, 
Roden DM, Christoffels VM, Marec HL, Wilde AA, Probst V, Schott JJ, Dina C, 
Redon R. Common variants at SCN5A-SCN10A and HEY2 are associated with 
Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nature 
Genetics 45(9): 1044-9, 2013. 
 Hayashi H, Murakami Y, Horie M. Pitfall of the meta-analysis regarding early 
repolarization pattern. J Am Coll Cardiol. 62(1): 86, 2013. 
 Smith JL, Reloj AR, Nataraj PS, Bartos DC, Schroder EA, Moss AJ, Ohno S, Horie 
M, Anderson CL, January CT, Delisle BP. Pharmacological Correction of Long 
QT-linked Mutations in KCNH2 (hERG) Increases the Trafficking of Kv11.1 
Channels Stored in the Transitional ER. American Journal of Physiology-Cell 
Physiology 305(9):C919-30, 2013. 
 Ishikawa T, Takahashi N, Ohno S, Sakurada H, Nakamura K, On YK, Park JE, 
Makiyama T, Horie M, Arimura T, Makita N, Kimura A. Novel SCN3B Mutation 
Associated With Brugada Syndrome Affects Intracellular Trafficking and Function 
of Nav1.5. Circulation Journal 77: 959-967, 2013. 
 Hisamatsu T, Ohkubo T, Miura K, Yamamoto T, Fujiyoshi A, Miyagawa A, Kadota A, 
Takashima N, Nagasawa S, Kita Y, Murakami Y, Okayama A, Horie M, Okamura T, 
Ueshima H. Is more aggressive prevention of coronary artery disease required for 
patients with early repolarization syndrome?--Reply. Circulation Journal 77: 1643, 
2013. 
 Kawaguchi T, Hayashi H, Naiki N, Sakai H, Yamamoto T, Fujita M, Horie M. 
Spontaneous coronary artery spasm accidentally detected by 320-row 
multi-detector computed tomography ． Journal of Cardiology Cases 
8(2):e85-e87,2013 
 Ichiro Nakae , Hideki Hayashi , Kenichi Mitsunami , Minoru Horie.Clinical 
signi?cance of lung iodine-123 metaiodobenzylguanidineuptake assessment in 
Parkinson’s and heart diseases. Ann Nucl Med 27: 737-47,2013. 
 Barc J, Bezzina C, Mizusawa Y, Remme C, Gourraud J, Verkerk A, Schwartz P, 
Guicheney P, Antzelevitch C, Schulze-Bahr E, Behr E, Tfelt-Hanson J, Kaab S, 
Watanabe H, Horie M, Makita N, Shimizu W, Roden D, Christoffels V, Gessler M, 
Wilde A, Probst V, Schott J, Dina C, Redon R. Genome-wide association analysis 
identifies 3 common variants predisposing to brugada syndrome, a rare disease 
with high risk of sudden cardiac death. Heart Rhythm. 10(11): 1743-4, 2013. 
 Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, 
Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz 
PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS Expert Consensus 
Statement on the Diagnosis and Management of Patients with Inherited Primary 
Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 
2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 10(12): 
1932-63, 2013. 
 Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, 
Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz 
PJ, Shimizu W, Tomaselli G, Tracy C; Document Reviewers, Ackerman M, 
Belhassen B, Estes NA 3rd, Fatkin D, Kalman J, Kaufman E, Kirchhof P, 
Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge SP, Campbell RM, Martin 
ET, Quek SC. Executive summary: HRS/EHRA/APHRS expert consensus 
statement on the diagnosis and management of patients with inherited primary 
arrhythmia syndromes. Europace. 15(10): 1389-406, 2013. 
 Hayashi H, Shibukawa T, Horie M. Restoration of aberrant conduction induced by 




 Ashihara T, Haraguchi R, Nakazawa K, Namba T, Ikeda T, Nakazawa Y, Ozawa T, 
Ito M, Horie M, Trayanova NA: The role of fibroblasts in complex fractionated 
electrograms during persistent/permanent atrial fibrillation implications for 
electrogram-based catheter ablation. Circ Res. 110(2): 275-284, 2012. 
 Ijiri T, Ashihara T, Umetani N, Igarashi T, Haraguchi R, Yokota H, Nakazawa K: A 
kinematic approach for efficient and robust simulation of cardiac beating motion. 
PLoS ONE. 7(5): e36706, 2012.  
 Yamazaki M, Honjo H, Ashihara T, Harada M, Sakuma I, Nakazawa K, Trayanova 
N, Horie M, Kalifa J, Jalife J, Kamiya K, Kodama I: Regional cooling facilitates 
termination of spiral-wave reentry through unpinning of rotors in rabbit hearts. 
Heart Rhythm. 9(1): 107-114, 2012. 
 Kato S, Honjo H, Takemoto Y, Takanari H, Suzuki T, Okuno Y, Opthof T, Sakuma I, 
Inada S, Nakazawa K, Ashihara T, Kodama I, Kamiya K: Pharmacological blockade 
of IKs destabilizes spiral-wave reentry under β-adrenergic stimulation in favor of 
its early termination. J Pharmacol Sci. 119(1): 52-63, 2012.  
 Miyamoto A, Hayashi H, Yoshino T, Kawaguchi T, Taniguchi A, Ito H, Sugimoto Y, 
Ito M, Makiyama T, Xue JQ, Murakami Y, Horie M: Clinical and 
electrocardiographic characteristics of patients with short QT interval in a large 
hospital-based population. Heart Rhythm. 9(1): 66-74, 2012. 
 Shizuta S, Ando K, Nobuyoshi M, Ikeda T, Yoshino H, Hiramatsu S, Kazatani Y, 
Yamashiro K, Okajima K, Kajiya T, Kobayashi Y, Kato T, Fujii S, Mitsudo K, Inoue 
K, Ito H, Haruna Y, Doi T, Nishio Y, Ozasa N, Nishiyama K, Kita T, Morimoto T, 
Kimura T, for the PREVENT-SCD Investigators: Prognostic utility of T-wave 
alternans in a real-world population of patients with left ventricular dysfunction: 
the PREVENT-SCD study. Clin Res Cardiol. 101(2): 89-99, 2012. 
 Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, 
Itoh H, Yokode M, Kita T, Horie M, Kimura T: A novel gain-of-function KCNJ2 
mutation associated with short QT syndrome impairs inward rectification of Kir2.1 
currents. Cardiovasc Res. 93(4): 666-673, 2012. 
 Makita N, Seki A, Sumitomo N, Fukuhara S, Watanabe H, Shimizu W, Bezzina CR., 
Hasdemir C, Mugishima H, Makiyama T, Baruteau A, Baron E, Horie M, Hagiwara 
N, Wilde AAM, Probst V, Marec HL, Delmar M, Roden DM, Mochizuki N, Schott JJ: 
A Connexin 40 mutation associated with a malignant variant of familial 
progressive heart block type-1. Circ Arrhythm Electrophysiol. 5(1): 163-172, 2012. 
 Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, 
Shizuta S, Tomohisa Tada T, Tazaki J, Shiomi H, Kato Y, Hayano M, Abe M, Ehara 
N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, 
Nakano A, Tei C, Horie M, Ogawa H, Tamura T, Shirotani M, Takahashi M, Ishii I, 
Tatami R, Suwa T, Takizawa A, Takahashi M, Takeda T, Nohara R, Fujiwara H, 
Mitsudo K, Nobuyoshi M, Kita T, Kimura T, on behalf of the CREDO-Kyoto 
PCI/CABG registry cohort-2 investigators: Comparison of three-year clinical 
outcomes after transradial versus transfemoral percutaneous coronary 
intervention. Am J Cardiol. 110(7): 924-932, 2012.  
 Wu J, Ding WG, Matsuura H, Horie M: Regulatory mechanisms underlying the 
modulation of GIRK1/GIRK4 heteromeric channels by P2Y receptors. Pflugers Arch. 
463(4): 625-633, 2012. 
 Aizawa Y, Sato A, Watanabe H, Chinushi M, Furushima H, Horie M, Kaneko Y, 
Imaizumi T, Okubo K, Watanabe I, Shinozaki T, Aizawa Y, Fukuda, Joo K, 
Haissaguerre M: Dynamicity of the J wave in idiopathic ventricular fibrillation 
with a special reference to pause-dependent augmentation of the J wave. J Am Coll 
Cardiol. 59(22): 1948-1953, 2012. 
 Okayasu H, Ozeki Y, Fujii K, Takano Y, Saeki Y, Hori H, Horie M, Higuchi T, 
Kunugi H, Shimoda K: Pharmachotherapeutic determinants for QTc interval 
prolongation in Japanese patients with mood disorder. Pharmacopsychiatry. 45(7): 
279-283, 2012. 
 Kinoshita T, Asai T, Suzuki T, Matsubayashi K, Horie M: Time course and 
prognostic implications of QT interval in patients with coronary artery disease 
undergoing coronary bypass surgery. J Cardiovasc Electrophysiol. 23(6): 645-649, 
2012. 
 Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, 
Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, 
Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe 
I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N: Response to letter 
regarding article, "Electrocardiographic characteristics and SCN5A mutations in 
idiopathic ventricular fibrillation associated with early repolarization". Circ 
Arrhythm Electrophysiol. 5(2): e60-e61, 2012. 猖獗 
 Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S, 
Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura 
Y, Zang WJ, Ito M, Matsuura H, Horie M: Phenotype variability in patients 
carrying KCNJ2 mutations. Circ Cardiovasc Genet. 5: 344-353, 2012. 
 Shiomi H, Morimoto T, Hayano M, Furukawa Y, Nakagawa Y, Tazaki J, Imai M, 
Yamaji K, Tada T, Natsuaki M, Saijo S, Funakoshi S, Nagao K, Hanazawa K, Ehara 
N, Kadota K, Iwabuchi M, Shizuta S, Abe M, Sakata R, Okabayashi H, Hanyu M, 
Yamazaki F, Shimamoto M, Nishiwaki N, Imoto Y, Komiya T, Horie M, Fujiwara H, 
Mitsudo K, Nobuyoshi M, Kita T, Kimura T, CREDO-Kyoto PCI/CABG Registry 
Cohort-2 Investigators: Comparison of long-term outcome after percutaneous 
coronary intervention versus coronary artery bypass grafting in patients with 
unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG 
Registry Cohort-2). Am J Cardiol. 110(7): 924-932, 2012. 
 Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, 
Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, 
Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe 
I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N: Clinical characteristics 
and risk of arrhythmia recurrences in patients with idiopathic ventricular 
fibrillation associated with early repolarization. Int J Cardiol. 159(3): 238-240, 
2012. 
 Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T, Ohno Y, 
Tohyama S, Okata S, Seki T, Kuroda Y, Yae K, Hashimoto H, Tanaka T, Hattori F, 
Sato T, Miyoshi S, Takatsuki S, Murata M, Kurokawa J, Furukawa T, Makita N, 
Aiba T, Shimizu W, Horie M, Kamiya K, Kodama I, Ogawa S, Fukuda K: Disease 
characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc 
Res. 95: 419-429, 2012.  
 Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, 
Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Ehara N, 
Inada T, Kaburagi S, Hamasaki S, Tei C, Nakashima H, Ogawa H, Tatami R, Suwa 
S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, 
CREDO-Kyoto PCI/CABG registry cohort-2 investigators: Incidence and outcome of 
surgical procedures after coronary bare-metal and drug-eluting stent implantation: 
a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc 
Interv. 5(2): 237-246, 2012. 
 Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, 
Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi 
T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, 
Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, 
Kimura T, on behalf of the CREDO-Kyoto PCI/CABG Registry Cohort-2 
Investigators: Duration of dual antiplatelet therapy and long-term clinical outcome 
after coronary drug-eluting stent implantation: landmark analyses from the 
CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv. 5(3): 381-391, 
2012.  
 Shiomi H, Nakagawa Y, Morimoto T, Furukawa Y, Nakano A, Shirai S, Taniguchi R, 
Yamaji K, Nagao K, Suyama T, Mitsuoka H, Araki M, Takashima H, Mizoguchi T, 
Eisawa H, Sugiyama S, Kimura T, CREDO-Kyoto AMI investigators: Association of 
onset to balloon and door to balloon time with long term clinical outcome in patients 
with ST elevation acute myocardial infarction having primary percutaneous 
coronary intervention: observational study. BMJ. 344: e3257, 2012. 
 Takigawa M, Kawamura M, Noda T, Yamada Y, Miyamoto K, Okamura H, Satomi 
K, Aiba T, Kamakura S, Sakaguchi T, Mizusawa Y, Itoh H, Horie M, Shimizu W: 
Seasonal and circadian distributions of cardiac events in genotyped patients with 
congenital long QT syndrome. Circ J. 76(9): 2112-2118, 2012. 
 Nakajima T, Wu J, Kaneko Y, Ashihara T, Ohno S, Irie T, Ding WG, Matsuura H, 
Kurabayashi M, Horie M: KCNE3 T4A as a genetic background of Brugada-pattern 
electrocardiogram. Circ J. 76(12): 2763-2772, 2012.  
 Kawaguchi T, Hayashi H, Miyamoto A, Yoshino T, Taniguchi A, Naiki N, Sugimoto 
Y, Ito M, Xue J-Q, Murakami Y, Horie M: Prognostic implications of progressive 
cardiac conduction disease. Circ J. 77(1):60-7, 2012. 
 Momomura S, Tsutsui H, Sugawara Y, Ito M, Mitsuhashi T, Fukamizu S, Noro M, 
Matsumoto N, Tejima T, Sugi K: Clinical efficacy of cardiac resynchronization 
therapy with an implantable defibrillator in a Japanese population: results of the 
MIRACLE-ICD outcome measured in Japanese indication (MOMIJI) study. Circ J. 
76(8): 1911-1919, 2012. 
 Isono T, Matsumoto T, Wada A, Suzaki M, Chano T. A global transcriptome analysis 
of a dog model of congestive heart failure with the human genome as a reference. J 
Card Fail. 18(11):872-8, 2012. 
 Burgess DE, Bartos DC, Reloj AR, Campbell KS, Johnson JN, Tester DJ, Ackerman 
MJ, Fressart V, Denjoy I, Guicheney P, Moss AJ, Ohno S, Horie M, Delisle BP. 
High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the 




 Haraguchi R, Ashihara T, Namba T, Tsumoto K, Murakami S, Kurachi Y, Ikeda T, 
Nakazawa K: Transmural dispersion of repolarization determines scroll wave behavior 
during ventricular tachyarrhythmias. Circ J. 75(1): 80-88, 2011. 
 Trayanova N, Constantino J, Ashihara T, Plank G: Modeling defibrillation of the heart: 
Approaches and insights. IEEE Rev Biomed Eng. 4: 89-102, 2011. 
 Takanari H, Honjo H, Takemoto Y, Suzuki T, Kato S, Harada M, Okuno Y, Ashihara T, 
Opthof T, Sakuma I, Kamiya K, Kodama I: Bepridil facilitates early termination of 
spiral-wave reentry in two-dimensional cardiac muscle through an increase of intercellular 
electrical coupling. J Pharmacol Sci. 115(1): 15-26, 2011. 
 Matsumoto T, Eguchi Y, Oda H, Yamane T, Tarutani Y, Ozawa T, Hayashi H, Nakae I, 
Horie M, Urade Y: Lipocalin-type prostaglandin D synthase is associated with coronary 
vasospasm and vasomotor reactivity in response to acetylcholine. Circ J. 75: 897-904, 
2011. 
 Li P, Ninomiya H, KurataY, Kato M, Miake J, Yamamoto Y, Igawa O, Nakai A, Higaki K, 
Toyoda F, Wu J, Horie M, Shirayoshi Y, Hiraoka M, Hisatome I: Reciprocal control of 
hERG stability by Hsp70 and Hsc70 with implication for restoration of LQT2 mutant 
stability. Circ Res. 108: 458-468, 2011. 
 Miyamoto A, Hayashi H, Makiyama T, Yoshino T, Mizusawa Y, Sugimoto Y, Ito M, Xue 
JQ, Murakami Y, Horie M: Risk determinants in individuals with a spontaneous type 1 
Brugada ECG. Circ J. 75: 844-851, 2011. 
 Matsumoto T, Horie M: Angiotensin-converting enzyme inhibition and fibrinolytic balance. 
Hypertens Res. 34: 448-449, 2011. 
 Nishiyama K, Tsutamoto T, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M: 
Biological variation of brain natriuretic peptide and cardiac events in stable outpatients 
with nonischemic chronic heart failure. Circ J. 75: 341-347, 2011. 
 Ohno S, Zankov DP, Ding WG, Itoh H, Makiyama T, Doi T, Shizuta S, Hattori T, 
Miyamoto A, Naiki N, Hancox JC, Matsuura H, Horie M: KCNE5 (KCNE1L) variants are 
novel modulators of brugada syndrome and idiopathic ventricular fibrillation. Circ 
Arrhythm Electrophysiol. 4(3): 352-361, 2011. 
 Doi T, Makiyama T, Morimoto T, Haruna Y, Tsuji K, Ohno S, Akao M, Takahashi Y, 
Kimura T, Horie M: A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and 
causes a limited form of andersen-tawil syndrome. Circ Cardiovasc Genet. 4: 253-260, 
2011. 
 Shimizu W, Horie M: Phenotypical manifestations of mutations in genes encoding subunits 
ofcardiac potassium channels. Circ Res. 109: 97-109, 2011. 
 Takagi Y, Yasuda S, Tsunoda R, Ogata Y, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, 
Sueda S, Sato T, Ogawa S, Kubo N, Momomura S, Ogawa H, Shimokawa H; Japanese 
Coronary Spasm Association: Clinical characteristics and long-term prognosis of 
vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry 
study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol. 4(3): 
295-302, 2011. 
 Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, Yamamoto T, Horie 
M: Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic 
dilated cardiomyopathy. Circ J. 75(3): 656-661, 2011. 
 Tsumoto K, Ashihara T, Haraguchi R, Nakazawa K, Kurachi Y: Roles of subcellular Na+ 
channel distributions in the mechanism of cardiac conduction. Biophys J. 100(3): 554-563, 
2011. 
 Nishiyama K, Tsutamoto T, Kawahara C, Yamaji M, Sakai H, Yamamoto T, Fujii M, Horie 
M: Relationship between biological variation in B-type natriuretic peptide and plasma renin 
concentration in stable outpatients with dilated cardiomyopathy. Circ J. 75(8): 1897-1904, 
2011. 
 Tsuji K, Akao M, Ishii TM, Ashihara T, Makiyama T, Ohno S, Toyoda F, Nishio Y, 
Sakaguchi T, Matsuura H, Horie M: Identification and functional characterization of 
KCNQ1 mutations around the exon7-intron7 junction affecting the splicing process. BBA - 
Molecular Basis of Disease. 1812(11): 1452-1459, 2011. 
 Yoshino T, Nakae I, Matsumoto T, Mitsunami K, Horie M: Association between 
brachial-ankle pulse wave velocity and endothelium-dependent and -independent coronary 
vasomotor function. Clin Exp Pharmacol Physiol. 38(1): 34-41, 2011. 
 Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, 
Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, Sato M, 
Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, 
Horie M, Aizawa Y, Shimizu W, Makita N: Electrocardiographic characteristics and 
SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. 
Circ Arrhythm Electrophysiol. 4(6): 874-881, 2011. 
 Kawahara C, Tsutamoto T, Sakai H, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie 
M: Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable 
outpatients with nonischemic chronic heart failure. Am Heart J. 162(4): 639-645, 2011. 
 Funakoshi S, Furukawa Y, Ehara N, Morimoto T, Kaji S, Yamamuro A, Kinoshita M, Kitai 
T, Kim K, Tani T, Kobori A, Nasu M, Okada Y, Kita T, Kimura T; CREDO-Kyoto 
Investigators: Clinical characteristics and outcomes of Japanese women undergoing 
coronary revascularization therapy. Circ J. 75(6): 1358-1367, 2011. 
 Tsutamoto T, Sakai H, Ibe K, Yamaji M, Kawahara C, Nakae I, Fujii M, Yamamoto T, 
Horie M: Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in 
non-diabetic patients with dilated cardiomyopathy. Circ J. 75(9): 2160-2166, 2011. 
 Kimura H, Mizusawa Y, Itoh H, Miyamoto A, Kawamura M, Kawaguchi T, Naiki N, Oka Y, 
Ohno S, Makiyama T, Ito M, Horie M: Carvedilol, a non-selective β-with α1-blocker is 
effective in long QT syndrome type 2. J Arrhythm. 27; 324-331, 2011. 
 Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Tazaki J, Kato Y, Hayano M, 
Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, 
Aoyama T, Doi O, Hattori R, Tatami R, Suwa S, Takizawa A, Takatsu Y, Takahashi M, 
Kato H, Takeda T, Lee J-D, Nohara R, Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo 
Km Nobuyoshi M, Kita T: Association of the use of proton pump inhibitors with adverse 
cardiovascular and bleeding outcomes after percutaneous coronary intervention in the 
Japanese real world clinical practice. Cardiovasc Interv Ther. 26: 222-233, 2011. 
 Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, 
Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, 
Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Tatami R, Suwa 
S, Takizawa A, Takatsu Y, Takahashi M, Kato H, Takeda T, Lee JD, Nohara R, Ogawa H, 
Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T: Long-term 
safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world 
clinicalpractice in Japan. Cardiovasc Interv Ther. 26: 234-245, 2011. 
 Miyamoto A, Hayashi H, Yoshino T, Kawaguchi T, Taniguchi A, Itoh H, Sugimoto Y, Itoh 
M, Makiyama T, Xue JQ, Murakami Y, Horie M: Clinical and electrocardiographic 
characteristics of patients with short QT interval in a large hospital-based population. 
Heart Rhythm. 9(1): 66-74, 2011. 
 
【２０１０】 
 Ozeki Y, Fujii K, Kuromoto N, Yamada N, Okawa M, Aoki T, Takahashi J, Narita M, Ishida 
N, Saito O, Horie M, Kunugi H: QTc prolongation and antipsychotic medication in 1017 
patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 34: 401-405, 
2010. 
 Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M: 
Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. 
Am Heart J. 159: 63-67, 2010.  
 Tsutamoto T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M: 
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin 
II and left ventricular mass index in patients with hypertension. Hypertens Res. 33: 
118-122, 2010. 
 Wu J, Shimizu W, Ding W-G, Ohno S, Toyada F, Itoh H, Zang W-J, Miyamoto Y, 
Kamakura S, Matsuura H, Nademanee J, Brugada J, Brugada P, Brugada R, Vatta M, 
Towbin JA, Antzelevitch C, Horie M: KCNE2 modulation of Kv4.3 current and its 
potential role in fatal rhythm disorders. Heart Rhythm. 7: 199-205, 2010. 
 Horigome H, Nagashima M, Sumitomo N, Yoshinaga M, Ushinohama H, Iwamoto M, 
Shiono J, Ichihashi K, Hasegawa S, Yoshikawa T, Matsunaga T, Goto H, Waki K, Arima M, 
Takasugi H, Tanaka Y, Miura M, Ogawa K, Suzuki H, Yamagishi H, Ikoma M, Suda K, 
Takagi J, Sato J, Shimizu H, Saiki H, Hoshiai M, Ichida F, Takeda S, Takigiku K, Inamura 
N, Kajino H, Murakami T, Shimizu W, Horie M: Clinical characteristics and genetic 
background of congenital long QT syndrome diagnosed in fetal, neonatal and infantile life. 
A nation-wide questionnaire survey in Japan. Circ Arrhythm Electrophysiol. 3: 10-17, 
2010. 
 Ishida K, Hayashi H, Miyamoto A, Sugimoto Y, Ito M, Murakami Y, Horie M: P-wave and 
the development of atrial fibrillation. Heart Rhythm. 7: 289-294, 2010.  
 Matsumoto T, Fujita M, Sawamura T, Kakino A, Sato Y, Fujita Y, Matsuda H, Nakanishi M, 
Uchida K, Nakae I, Kanda H, Yoshida A, Miwa K, Hayashi H, Mitsunami K, Horie M: 
Pitavastatin reduces Lectin-Like oxidized low-density lipoprotein Receptor-1 ligands in 
hypercholesterolemic humans. Lipids. 45; 329-335, 2010.  
 Watanabe H, Makiyama T, Koyama T, Kannankeril PJ, Seto S, Okamura K, Oda H, Itoh H, 
Okada M, Tanabe N, Yagihara N, Kamakura S, Horie M, Aizawa Y, Shimizu W: High 
prevalence of early repolarization in short QT syndrome. Heart Rhythm. 7: 647-652, 
2010. 
 Constantino J, Long Y, Ashihara T, Trayanova NA: Tunnel propagation following 
defibrillation with ICD shocks: Hidden postshock activations in the left ventricular wall 
underlie isoelectric window. Heart Rhythm. 7(7): 953-961, 2010. 
 Toyoda F, Ding W-G, Zankov DP, Omatsu-Kanbe M, Isono T, Horie M, Matsuura H: 
Characterization of the rapidly activating delayed rectifier potassium current, IKr, in HL-1 
mouse atrial myocytes. J Membr Biol. 235: 73-87, 2010. 
 Yasuda S, Hiramatsu S, Odashiro K, Maruyama T, Tsuji K, Horie M: A family of hereditary 
long QT syndrome caused by Q738X HERG mutation. Int J Cardiol. 144: 69-72, 2010.  
 Yamamura K, Muneuchi J, Uike K, Ikeda K, Inoue H, Takahata Y, Shiokawa Y, Yoshikane 
Y, Makiyama T, Horie M, Hara T: A novel SCN5A mutation associated with the linker 
between III and IV domains of Nav1.5 in a neonate with fatal long QT syndrome. Int J 
Cardiol. 145: 61-64, 2010.  
 Horie M: Bi-directional ventricular tachycardia revised. J Arrhythm. 26: 3-4, 2010. 
 Itoh H, Shimizu W, Hayashi K, Yamagata K, Sakaguchi T, Ohno S, Makiyama T, Akao M, 
Ai T, Noda T, Miyazaki A, Miyamoto Y, Yamagishi M, Kamakura S, Horie M: Long QT 
syndrome with compound mutations is associated with a more severe phenotype: A 
Japanese multicenter study. Heart Rhythm. 7: 1411-1418, 2010. 
 Matsumoto T, Takashima H, Nakae I, Yamane T, Hayashi H, Horie M; for the SPAIC 
(Shiga tissue Plasminogen Activator In Coronary circulation) Investigators: 
Angiotensin-converting enzyme inhibition augments coronary release of tissue 
plasminogen activator in women but not in men. Hypertension. 56(3): 364-368, 2010. 
 Yoshino T, Nakae I, Matsumoto T, Mitsunami K, Horie M: Relationship between exercise 
capacity and cardiac diastolic function assessed by time-volume curve from 16-frame gated 
myocardial perfusion SPECT. Ann Nucl Med. 24: 469-476, 2010. 
 Oka Y, Itoh H, Ding WG, Shimizu W, Makiyama T, Ohno S, Nishio Y, Sakaguchi T, Akashi 
M, Kawamura M, Matsuura H, Horie M: Atrioventricular block-induced Torsades de 
Pointes with clinical and molecular backgrounds similar to ongenital long QT syndrome. 
Circ J. 17: 2535-2571, 2010. 
 Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata 
K, Makimoto H, Miyamoto Y, Kamakura S, Horie M: Heart rate-dependent variability of 
cardiac events in type 2 congenital long-QT syndrome. Europace. 12: 1623-1629, 2010.  
 Hayashi H, Miyamoto A, Ishida K, Yoshino T, Sugimoto Y, Ito M, Horie M: Prevalence and 
QT interval of early repolarization in a hospital-based population. J Arrhythm. 26: 127-133, 
2010.  
 Nakae I, Mitsunami K, Yoshino T, Omura T, Tsutamoto T, Matsumoto T, Morikawa S, 
Inubushi T, Horie M: Clinical features of myocardial triglyceride in different types of 
cardiomyopathy assessed by proton magnetic resonance spectroscopy: Comparison with 
myocardial creatine. J Card Fail. 16: 812-822, 2010. 
 Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M: Effect 
of eplerenone versus spironolactone on cortisol and hemoglobin a1(c) levels in patients 
with chronic heart failure. Am Heart J. 160: 915-921, 2010. 
 
【２００９】 
 Ikrar T, Hanawa H, Watanabe H, Aizawa Y, Ramadan MM, Chinushi M, Horie M, Aizawa 
Y: Evaluation of channel function after alteration of amino acid residues at the pore center 
of KCNQ1 channel. BBRC. 378(3): 589-594, 2009. 
 Kawamura M, Ozawa T, Yao T, Ashihara T, Sugimoto Y, Yagi T, Itoh H, Ito M, 
Makiyama T, Horie M: Dynamic change in ST-segment and spontaneous occurrence of 
ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A 
gene during long-term follow-up. Circ J. 73: 584-588, 2009. 
 Wu J, Ding WG, Matsuura H, Tsuji K, Zang WJ, Horie M: Inhibitory actions of the 
phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel. Brit J 
Pharm. 156: 377-387, 2009. 
 Zankov DP, Yoshida H, Tsuji K, Toyoda F, Ding WG, Matsuura H, Horie M: Adrenergic 
regulation of the rapid component of delayed rectifier K+ current: Implications for 
arrhythmogenesis in LQT2 patients. Heart Rhythm. 6(7): 1038-1046, 2009. 
 Itoh H, Sakaguchi T, Ashihara T, Ding G W, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, 
Ito M, Matsuura H, Horie M: A novel KCNH2 mutation as a modifier for short QT interval. 
Int J Cardiol. 137(1): 83-85, 2009. 
 Nakazawa Y, Ashihara T, Tsutamoto T, Ito M, Horie M: Endothelin-1 as a predictor of atrial 
fibrillation recurrence after pulmonary vein isolation. Heart Rhythm. 6(6): 725-730, 2009. 
 Ohno S, Toyoda F, Zankov D, Yoshida H, Makiyama T, Tsuji K, Honda T, Obayashi K, 
Matsuura H, Shimizu W, Miyamoto Y, Kamakura S, Kita T, Horie M: Novel KCNE3 
mutation reduces repolarizing potassium current and associated with long QT syndrome. 
Hum Mutat. 30: 557-563, 2009. 
 Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, 
Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, 
Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, 
Mitamura H; J-RHYTHM Investigators: Optimal treatment strategy for patients with 
paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J. 73: 242-248, 2009. 
 Yamashita T, Ogawa S, Sato T, Aizawa Y, Atarashi H, Fujiki A, Inoue H, Ito M, Katoh T, 
Kobayashi Y, Koretsune Y, Kumagai K, Niwano S, Okazaki O, Okumura K, Saku K, 
Tanabe T, Origasa H; J-BAF Investigators: Dose-response effects of bepridil in patients 
with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a 
multicenter, randomized, placebo-controlled, double-blind study (J-BAF Study). Circ J. 73: 
1020-1027, 2009. 
 Zankov DP, Toyoda F, Omatsu-Kanbe M, Matsuura M, Horie M: Angiotensin II type 1 
receptor mediates partially hyposmotic-induced increase of IKs current in guinea pig 
atrium. Pflugers Arch. 458: 837-849, 2009. 
 Nishio Y, Makiyama T, Itoh H, Sakaguchi T, Ohno S, Gong Y-Z, Yamamoto S, Ozawa T, 
Ding W-G, Toyoda F, Kawamura M, Akao M, Matsuura H, Kita T, Horie M: D85N, a 
KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll 
Cardiol. 54(9): 812-819, 2009. 
 Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kanda H, Kita Y, Kadowaki T, Tsujita Y, 
Turin T C, Horie M, Miki T, Ueshima H: Association between polymorphism of the 
AGTR1 and cardiovascular events in a Japanese general sample (The Shigaraki Study). Int 
J Cardiol. 136(3): 354-355, 2009. 
 Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, 
Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake 
A, Mitamura H, Kodama I, Kamakura S: Prevalence of atrial fibrillation in the general 
population of Japan: An analysis based on periodic health examination. Int J Cardiol. 137: 
102-107, 2009. 
 Okamura T, Sekikawa A, Kadowaki T, El-Saed A, Abbott DR, Curb JD, Edmundowicz D, 
Nakamura Y, Murata K, Kashiwagi A, Kim ST, Evans RW, Zmuda JM, Maegawa H, 
Hozawa A, Mitsunami K, Nisio Y, Iva MG, Horie M, Miyamastu N, Murakami Y, Kuller 
LH, Ueshima H: Cholesteryl ester transfer protein, coronary calcium and intima-media 
thickness of the carotid artery in middle-aged Japanese men. Am J Cardiol. 104(6): 
818-822, 2009. 
 Nishiyama K, Tsutamoto T, Tanaka T, Fujii M, Yamamoto T, Yamaji M, Horie M: Plasma 
NT-proBNP as a more reliable biomarker of endogenous cardiac natriuretic peptides Than 
BNP during carperitide infusion. Int Heart J. 50(2): 183-190, 2009. 
 Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie 
M: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart 
failure. Circ J. 73: 1067-1073, 2009. 
 Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, Ogawa S, Okumura K, 
Tsuchihashi K, Sugi K, Makita N, Hagiwara N, Inoue H, Atarashi H, Aihara N, Shimizu W, 
Kurita T, Suyama K, Noda T, Satomi K, Okamura H, Tomoike H: Long-term prognosis of 
probands with Brugada-pattern ST-Elevation in leads V1-V3. Circ Arrhythm 
Electrophysiol. 2(5): 495-503, 2009. 
 Itoh H, Sakaguchi T, Ding WS, Watanabe E, Watanabe I, Nishio Y, Makiyama T, Ohno S, 
Akao M, Higashi Y, Zenda N, Kubota T, Mori C, Okajima K, Haruna T, Miyamoto A, 
Kawamura M, Ishida K, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Sugimoto Y, 
Ashihara T, Hayashi H, Ito M, Imoto K, Matsuura H, Horie M: Latent genetic backgrounds 
and molecular pathogenesis in drug-induced long QT syndrome. Circ Arrhythm 
Electrophysiol. 2(5): 511-523, 2009. 
 Tsutamoto T, Kawahara C, Yamaji M, Nishiyama K, Fujii M, Yamamoto T, Horie M: 
Relationship between renal function and serum cardiac troponin T in patients with chronic 
heart failure. Eur J Heart Fail. 11(7): 653-658, 2009. 
 Tsutamoto T, Tanaka T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie 
M: Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass 
index in patients with essential hypertension. Hypertens Res. 32(8): 670-674, 2009. 
 Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M: 
Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: 
The impact of oxidative stress. Circ Heart Fail. 2: 608-615, 2009. 
 Nishiyama K, Tsutamoto T, Yamaji M, Kawahara C, Yamamoto T, Fujii M, Horie M: Dose- 
Dependent prognostic effect of carvedilol in patients with chonic heart failure: Special 
reference to ranscardiac gragient of norepinephrine. Circ J. 73: 2270-2275, 2009. 
 Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie 
M: Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure 
patients with diabetes mellitus. Circ J. 73: 2264-2269, 2009. 
 Tsutamoto T, Yamaji M, Kawahara C, Nishiyama K, Fujii M, Yamamoto T, Horie M: Effect 
of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with 
non-ischaemic chronic heart failure. Eur J Heart Fail. 11(12): 1195-1201, 2009.  
 Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, Doi T, Hoshino K, 
Tamura T, Shizuta S, Abe M, Toma M, Morimoto T, Teramukai S, Fukushima M, Kita T, 
Kimura T; CREDO-Kyoto Investigators: Coronary risk factor profile and prognostic 




 Ashihara T, Constantino J, Trayanova NA: Tunnel propagation of postshock activations as 
a unified hypothesis for fibrillation induction and isoelectric window. Circ Res. 102(6): 
737-745, 2008. 
 Harada M, Honjo H, Yamazaki M, Nakagawa H, Ishiguro Y, Okuno Y, Ashihara T, Sakuma 
I, Kamiya K, Kodama I: Moderate hypothermia increases the chance of spiral wave 
collision in favor of self termination of ventricular tachycardia/fibrillation. Am J Physiol 
Heart Circ Physiol. 294(4): H1896-H1905, 2008.  
 Ijiri T, Ashihara T, Yamaguchi T, Takayama K, Igarashi T, Namba T, Shimada T, Haraguchi 
R, Nakazawa K: A procedural method for modeling the purkinje fibers of the heart. J 
Physiol Sci. 58(7): 481-486, 2008. 
 Takayama K, Ashihara T, Ijiri T, Igarashi T, Haraguchi R, Nakazawa K: A sketch-based 
interface for modeling myocardial fiber orientation that considers the layered structure of 
the ventricles. J Physiol Sci. 58(7): 487-492, 2008.  
 Matsumoto T, Fujita M, Tarutani Y, Yamane T, Takashima H, Nakae I, Horie M: 
Whole-body periodic acceleration enhances brachial endothelial function. Circ J. 72(1): 
139-143, 2008. 
 Ohno S, Kubota T, Yoshida H, Tsuji K, Makiyama T, Yamada S, Kuga K, Yamaguchi I, 
Kita T, Horie M: A novel mutation associated with Jervell and Lange-Nielsen syndrome in 
a Japanese family. Circ J. 72(5): 687-693, 2008.  
 Sakaguchi T, Shimizu W, Itoh H, Noda T, Miyamoto A, Nagaoka I, Oka Y, Ashihara T, Ito 
M, Tsuji K, Ohno S, Makiyama T, Kamakura S, Horie M: Age- and genotype-specific 
triggers for life-threatening arrhythmia in the genotyped long-QT syndrome. J Cardiovasc 
Electrophysiol. 19(8): 794-799, 2008. 
 Nagaoka I, Shimizu W, Itoh H, Yamamoto S, Sakaguchi T, Ashihara T, Ito M, Yoshida H, 
Ohno S, Miyamoto Y, Kamakura S, Akao M, Horie M: Mutation site dependent variability 
of cardiac events in LQT2 form of congenital long-QT syndrom. Circ J. 72(5): 694-699, 
2008. 
 Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, Ohno S, Nishio Y, Tsuji K, 
Itoh H, Kimura T, Kita T, Horie M: A novel SCN5Again-of-function mutation M1875T 
associated with familial atrial fibrillation. J Am Coll Cardiol. 52(16): 1326-1334, 2008.  
 Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, 
Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, 
Harada M, Uemura S, Saito Y: Effects of 3-hydroxy-3-methylglutaryl coenzyme A 
reductase inhibition on coronary spasm after withdrawal of Ca-channel blockers. J Am 
Coll Cardiol. 51(18): 1742-1748, 2008.  
 Tsutamoto T, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Nakae I, Ohnishi M, 
Wada A, Horie M: Beneficial effect of perindopril on cardiac sympathetic nerve activity 
and brain natriuretic Peptide in patients with chronic heart failure. Circ J. 72(5): 740-746, 
2008.  
 Nakae I, Matsuo S, Matsumoto T, Mitsunami K, Horie M: Augmentation Index and Pulse 
Wave Velocity as Indicators of Cardiovascular Stiffness. Angiology. 59: 421-426, 2008. .  
 Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T; The J-ACCESS Investigators: 
Prognostic Value of Normal Stress Myocardial Perfusion Imaging in Japanese Population. 
Circ J. 72(4): 611-617, 2008.  
 Tanaka T, Tsutamoto T, Nishiyama K, Sakai H, Fujii M, Yamamoto T, Horie M: Impact of 
oxidative stress on plasma adiponectin in patients with chronic heart failure. Circ J. 72(4): 
563-568, 2008.  
 Tanaka T, Tsutamoto T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Horie M: Effect of 
atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail. 
10(4): 360-366, 2008.  
 Tamaki S, Nakamura Y, Teramura M, Sakai M, 1, Takayama T, Okabayashi T, Kawashima 
T, Horie M: The factors contributing to whether or not hypertensive patients bring their 
home blood pressure record to the outpatient exam. Intern Med. 47(18): 1561-1565, 2008.  
 Makiyama T, Akao M, Haruna Y, Tsuji K, Doi T, Ohno S, Nishio Y, Kita T, Horie M: 
Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in 
Japanese patients with Brugada syndrome. Circ J. 72: 1705-1706, 2008.  
 Makita N, Behr E, Shimizu W, Horie M, Sunami A, Crotti L, Schulze-Bahr E, Fukuhara S, 
Mochizuki N, Makiyama T, Itoh H, Christiansen M, McKeown P, Miyamoto K, Kamakura 
S, Tsutsui H, Schwartz P J, George Jr.A, Roden D: The E1784K mutation in SCN5A is 
associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest. 
118(6): 2219-2229, 2008. 
 Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, 
Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y: In vivo and in vitro inhibition of 
monocyte adhesion to endothelial cells and endothelial adhesion molecules by 
eicosapentaenoic acid. Arteroiscler Thromb Vasc Biol. 28: 2173-2179, 2008.  
 Gong YZ, Ding WG, Wu J, Tsuji K, Horie M, Matsuura H: Cinnamyl-3, 
4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 
currents independently of lipoxygenase. Eur J Pharmacol. 600(1-3): 18-25, 2008.  
 Takayama T, Teramura M, Sakai H, Tamaki S, Okabayashi T, Kawashima T, Yamamoto T, 
Horie M, Suzuki T, Asai T: Perforated mitral valve aneurysm associated with 
Libman-Sacks endocarditis. Intern Med. 47(18): 1605-1608, 2008.  
 Nakae I, Matsuo S, Matsumoto T, Horie M: Clinical significance of diastolic function as an 
indicator of myocardial ischemia assessed by 16-frame gated myocardial perfusion SPECT. 
Ann Nucl Med. 22: 677-683, 2008.  
 Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, Ozaki Y, Waseda K, Oda H, Seiki K, 
Node K, Urade Y: Lipocalin-type prostaglandin D synthase is a powerful biomarker for 
severity of stable coronary artery disease. Atherosclerosis. 201(2): 385-391, 2008.  
 Sakaguchi T, Itoh H, Ding WG, Tsuji K, Nagaoka I, Oka Y, Ashihara T, Ito M, Yumoto Y, 
Zenda N, Higashi Y, Takeyama Y, Matsuura H, Horie M: Hydroxyzine, a first generation 
H1-receptor antagonist, inhibits human ether-a-go-go related gene (HERG) current and 
causes syncope in a patient with the HERG mutation. J Pharmacol Sci. 108(4): 462-471, 
2008.  
 Tsutamoto T, Nishiyama K, Sakai H, Tanaka T, Fujii M, Yamamoto T, Yamaji M, Horie M: 
Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. 
Eur J Heart Fail. 10(12): 1208-1214, 2008.  
 Horie M, Ishida K, Nishio Y, Nagaoka I, Matsui K: Genetic background of arrhythmogenic 
right ventricular dysplasia/Cardiomyopathy: Time to start asian registry. J Arrhythm. 24: 
195-199, 2008. 
 Matsuo S, Nakajima K, Kinuya S, Sato Y, Matsumoto N, Horie M: Cardiac scintigraphic 
findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like 
episodes: A case report. Exp Clin Cardiol. 13: 93-95, 2008. 
 Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, 
Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; 
CREDO-Kyoto Investigators: Better survival with statin administration after 
revascularization therapy in Japanese patients with coronary artery disease: perspectives 
from the CREDO-Kyoto registry. Circ J. 73: 1937-1945, 2009. 
 
【２００７】 
 Ohno S, Zankov D, Yoshida H, Tsuji K, Makiyama T, Itoh H, Akao M, Hancox JC, Kita T, 
Horie M: N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT 
syndrome. Heart Rhythm. 4(3): 332-340, 2007.  
 Tsuji K, Akao M, Ishii T, Ohno S, Makiyama T, Doi T, Haruna Y, Yoshida H, Nakashima T, 
Kita T, Horie M: Mechanistic basis for the pathogenesis of long QT syndrome caused by a 
splicing mutation in KCNQ1 gene. J Mol Cell Cardiol. 42(3): 662-669, 2007.  
 Tsujita Y, Nakamura Y, Zhang Q, Tamaki S, Nozaki A, Amamoto K, Kadowaki T, Kita Y, 
Okamura T, Horie M, Ueshima H: The association between high-density lipoprotein 
cholesterol level and cholestery1 ester transfer protein taqIB gene polymorphism is 
influenced by alcohol drinking in a population-based sample. Atherosclerosis. 191(1): 
199-205, 2007. 
 Nagatani Y, Takahashi M, Takazakura R, Nitta N, Murata K, Ushio N, Matsuo S, 
Yamamoto T, Horie M: Multidetector-row computed tomography coronary angiography: 
optimization of image reconstruction phase according to the heart rate. Circ J. 71(1): 
112-121, 2007. 
 Toda H, Ding WG, Yasuda Y.Toyoda F, Ito M, Matsuura H, Horie M: Stimulatory action of 
protein kinase Cvarepsilon isoform on the slow component of delayed rectifier K(+) 
current in guinea-pig atrial myocytes. Br J Pharmacol. 150: 1011-1021, 2007. 
 Sakai H, Tsutamoto T, Ishikawa C, Tanaka T, Fujii M, Yamamoto T, Takashima H, Horie 
M: Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion 
and extent of coronary artery stenosis in patients with stable coronary artery disease. Circ J. 
71(4): 499-505, 2007. 
 Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M: A novel clinical indicator using 
Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with 
cardiomyopathies. J Nucl Cardiol. 14(2): 215-220, 2007. 
 Itoh H, Tsuji K, Sakaguchi T, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Ashihara T, Ito 
M, Horie M, Imoto K: A paradoxical effect of lidocaine for the N406S mutation of SCN5A 
associated with Brugada syndrome. Int J Cardiol. 121(3): 249-252, 2007.  
 Takashima H, Matsumoto T, Nakae I, Yamane T, Horie M: Cigarette smoking impairs 
bradykinin-stimulated tissue plasminogen activator release in human coronary circulation. 
Thrombo Res. 120: 791-796. 2007.  
 Todo T, Haraguchi R, Namba T, Yao T, Ashihara T, Higashi M, Inada H, Nakazawa K: 
Development of “Cardiac Arrhythmia Risk Evaluation” system based on computer 
simulation. Proc IEEE/ICME Int Conf Complex Med Eng. 182-185, 2007.  
 Haraguchi R, Igarashi T, Owada S, Yao T, Namba T, Ashihara T, Ikeda T, Nakazawa K: 
Electrophysiological heart simulator equipped with sketchy 3-D modeling. Complex 
Medical Engineering: Springer-Verlag, 107-116, 2007. 
 Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T, Horie M: Total and 
high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic 
heart failure. Eur Heart J. 28: 1723-1730. 2007.  
 Nakae I, Mitsunami K, Matsuo S, Horie M: Creatine Depletion and Altered Fatty Acid 
Metabolism in Diseased Human Hearts: Clinical Investigation Using (1)H Magnetic 
Resonance Spectroscopy and (123)I BMIPP Myocardial Scintigraphy. Acta Radiol. 48(4): 
436-443, 2007.  
 Tsutamoto T, Sakai H, Ishikawa C, Fujii M, Tanaka T, Yamamoto T, Takashima H, Ohnishi 
M, Wada A, Horie M: Direct comparison of transcardiac difference between brain 
natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure. 
Eur J Heart Fail. 9(6-7): 667-673, 2007.  
 Tsutamoto T, Sakai H, Tanaka T, Fujii M, Yamamoto T, Wada A, Ohnishi M, Horie M: 
Comparison of active renin concentration and plasma renin activity as a prognostic 
predictor in patients with heart failure. Circ J. 71: 915-921, 2007.  
 Horie M, Ito H: Disorders of cardiac repolarization: Long QT and short QT syndromes. 
Circ J. 71: A50-A53. 2007.  
 Lu J, Zhu SM, Zang WJ, Xu XL, Luo HL, Yu XJ, Wang SP, Kong SS, Wu J, Horie M, Sun 
L: Protective mechanism of adenosine to the rat arterial endothelial dysfunction induced by 
hydrogen peroxide. Biol Pharm Bull. 30(7): 1206-1211, 2007. 
 Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M: Effect of efonidipine 
versus amlodipine on aldosterone in patients with hypertension. Hypertens Res. 30(8): 
691-697, 2007. 
 Tsutamoto T, Asai S, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Ohnishi M, 
Wada A, Saito Y, Horie M: Plasma level of cardiotrophin-1 as a prognostic predictor in 
patients with chronic heart failure. Eur J Heart Fail. 9(10): 1032-1037, 2007. 
 Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M: Comparison of the effects 
of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens 
Res. 30(8): 691-697, 2007.  
 Crotti L, Spazzolini C, Schwartz P, Shimizu W, Denjoy I, Schulze-Bahr E, 
Zaklyazminskaya E, Swan H, Ackerman M, Moss A, Wilde A, Horie M, Brink P, Insolia R, 
Ferrari G, Crimi G: The common long QT syndrome mutation KCNQ1/A341V causes 
unusually severe clinical manifestations in patients with different ethnic backgrounds: 
Toward a mutation-specific risk stratification. Circulation. 116: 2366-2375, 2007.  
 Tsutamoto T, Sakai H, Nishiyama K, Tanaka T, Fujii M, Yamamoto T, Horie M: Direct 
comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal 
proBNP and prognosis in patients with chronic heart failure. Circ J. 71(12): 1873-1878, 
2007. 
 Sumitomo N, Sakurada H, Taniguchi K, Matsumura M, Abe O, Miyashita M, Kanamaru H, 
Karasawa K, Ayusawa M, Fakamizu S, Nagaoka I, Horie M, Harada K, Hiraoka M: 
Association of atrial arrhythmia and sinus node dysfunction in patients with 
catecholaminergic polymorphic ventricular tachycardia. Circ J. 71(10): 1606-1609, 2007.  
 Sugimoto T, Hajiro T, Fujimoto T, Kojyo N, Horie M, Kashiwagi A: Thrombotic 
microangiopathy in an adult patient with clinically amyopathic dermatomyositis 
complicated with interstitial lung disease. Lupus. 16(12): 1004-1005. 2007. 
 Hayashi H, Shiferaw Y, Sato D, Nihei M, Lin S, Chen P, Garfinkel A, Weiss N J, Qu Z: 
Dynamic origin of spatially discordant alternans in cardiac tissue. Biophys J. 92: 448-460, 
2007. 
 Namba T, Haraguchi R, Igarashi T, Owada S, Yao T, Ashihara T, Todo T, Ikeda T, 
Nakazawa K: Development of graphical interface for modeling excitation map in the 
electrophysiological heart simulator. Proc IEEE/ICME Int Conf Complex Med Eng. 
168-171, 2007. 
 Namba T, Todo T, Yao T, Ashihara T, Haraguchi R, Nakazawa K, Ikeda T, Ohe T: 
Identification of local myocardial repolarization time by bipolar electrode potential. J 
Electrocardiol. 40(Suppl.6): S97-S102, 2007. 
 Takagi M, Yokoyama Y, Aonuma K, Aihara N, Hiraoka M; for the Japan Idiopathic 
ventricular fibrillation study (J-IVFS) investigators: Clinical characteristics and risk 
stratification in symptomatic and asymptomatic patients with Brugada syndrome. J 
Cardiovasc Electrophysiol. 18(12): 1244-1251, 2007. 
 Nakae I, Matsuo S, Tsutamoto T, Matsumoto T, Mitsunami K, Horie M: Assessment of 
cardiac function in patients with heart disease by quantitative gated myocardial perfusion 
SPECT. Ann Nucl Med. 21: 315-323, 2007. 
 
【２００６】 
 Dohke, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, Horie M: Proteomic analysis 
reveals significant alternations of cardiac small heat shock protein expression in congestive 
heart failure. J Cardiac Fail. 12(1): 77-84, 2006. 
 Hatada K, Washizuka T, Horie M, Watanabe H, Yamashita F, Chinushi M, Aizawa Y: 
Tumor necrosis factor-alpha inhibits the cardiac delayed rectifier K current via the 
asphingomyelin pathway. Biochem Biophys Res Commun. 344: 189-193, 2006. 
 Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M: Prediction of mortality by 
high-sensitivity C-reactive protein and brain natriuretic Peptide in patients with dilated 
cardiomyopathy. Circ J. 70: 857-863, 2006. 
 Lu J, Nishi T, Ashihara T, Schnider N, Amano A, Matsuda T, Kotera H: The influence of 
activation time on the contraction force of myocardial tissue: A simulation study. Conf 
Proc IEEE Eng Med Biol Soc. 1: 2900-2903, 2006. 
 Itoh H, Horie M, Ito M, Imoto K: Arrhythmogenesis in the short-QT syndrome associated 
with combined HERG channel gating defects: A simulation study. Circ J. 70(4): 502-508, 
2006. 
 Matsuo S, Nakae I, Matsumoto T, Horie M: Impact of endothelial dysfunction on left 
ventricular remodeling after successful primary coronary angioplasty for acute myocardial 
infarction: Analysis by quantitative ECG-gated SPECT. Ann Nucl Med. 20: 57-62, 2006. 
 Matsuo S, Sato Y, Nakae I, Masuda D, Matsumoto N, Horie M: Evaluation of cardiac 
resynchronization therapy in drug-resistant dilated-phase hypertrophic cardiomyopathy by 
means of Tc-99m sestamibi ECG-gated SPECT. Ann Nucl Med. 20(9): 643-647, 2006. 
 Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M: Iodine-123 BMIPP scintigraphy in the 
evaluation of patients with heart failure. Acta Radiol. 47: 810-816, 2006. 
 Ozawa T, Ito M, Tamaki S, Yao T, Ashihara T, Kita Y, Okamura T, Ueshima H, Horie M: 
Gender and age effects on ventricular repolarization abnormality in Japanese general 
carriers of G643S common single nucleotide polymorphism of KCNQ1 gene. Circ J. 
70(6): 645-650, 2006. 
 Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M: Serum Level of Uric 
Acid, Partly Secreted From the Failing Heart, is a Prognostic Marker in Patients With 
Congestive Heart Failure. Circ J. 70: 1006-1011, 2006. 
 Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Denjoy I, Schulze-Bahr E, Amlie JP, 
Timothy K, Shkolnikova M, Berul C, Bitner-Glindzicz M, Toivonen L, Horie M: The 
Jervell and Lange-Nielsen Syndrome. Molecular basis, natural history, and clinical 
outcome. Circulation. 113: 783-790, 2006. 
 Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T, Tsujita Y, Horie M, 
Miki T, Ueshima H: Relationship between metabolic syndrome and Trp64Arg 
polymorphism of the β3-Adrenergic receptor gene in a general sample: the Shigaraki study. 
Hypertens Res. 29(11): 891-896, 2006. 
 Tamaki S, Nakamura Y, Yoshino T, Matsumoto Y, Tarutani Y, Okabayashi T, Kawashima T, 
Horie M: The association between morning hypertension and metabolic syndrome in 
hypertensive patients. Hypertens Res. 29: 783-788, 2006. 
 Tsujita Y, Muraski J, Shiraishi I, Kato T, Kajstura J, Anversa P, Sussman MA: Nuclear 
Targeting of Akt Antagonizes Aspects of Cardiomyocyte Hypertrophy. Proc Natl Acad Sci 
U S A. 103(32): 11946-11951, 2006. 
 Tsutamoto T, Wada A, Sakai H, Ishikawa C, Tanaka T, Hayashi M, Fujii M, Yamamoto T, 
Dohke T, Ohnishi M, Takashima H, Kinoshita M, Horie M: Relationship between renal 
function and plasma brain natriuretic Peptide in patients with heart failure. J Am Coll 
Cardiol. 47: 582-586, 2006. 
 Yamane T, Matsumoto T, Nakae I, Takashima H, Tarutani Y, Tamaki S, Horie M: Impact of 
paraoxonase polymorphism (Q192R) on endothelial function in intact coronary circulation. 
Hypertens Res. 29(6): 417-422, 2006. 
 Zhang CT, Yasuno S, Kuwahara K, Zankov D, Kobori A, Makiyama T, Horie M: Blockade 
of Angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left 
ventricular hypertrophy. Circ J. 70(3): 335-341, 2006. 
 Zankov DP, Toyoda F, Ding WG, Matsuura H, Horie M: Angiotensin II potentiates IKs 
potassium current via AT1 receptors in guinea-pig atrial myocytes. Circulation. 113(10): 
1278-1286, 2006. 
 Zankov DP, Omatsu-Kanbe M, Toyoda F, Ding WG, Matsuura H, Isono T, Horie M: 
Response to letter regarding article, "Angiotensin II potentiates the slow component of 
delayed rectifier K+ Current via the AT1 receptor in guinea pig atrial myocytes". 
Circulation. 114: e556, 2006. 
 
【２００５】 
 Aiba T, Shizimu W, Inagaki M, Noda T, Miyoshi S, Ding W-G, Zankov DP, Toyoda F, 
Matuura H, Horie M, Sunagawa K: Cellular and ionic mechanism for drug-induced long 
QT syndrome and effectiveness of verapamil. J Am Coll Cardiol. 45: 300-307, 2005. 
 Ashihara T, Trayanova NA: Cell and tissue responses to electric shocks. Europace. 7: 
155-165, 2005. 
 Hamamoto T, Tanaka H, Mani H, Tanabe T, Fujiwara K, Nakagami T, Horie M, Oyamada 
M, Takamatsu T: In situ Ca2+ dynamics of Purkiinje fibers and its interconnection with 
subjacent ventricular myocytes. J Mol Cell Cardiol. 38: 561-569, 2005. 
 Haraguchi R, Igarashi T, Owada S, Yao T, Namba T, Ashihara T, Ikeda T, Nakazawa K: 
Electrophysiological heart simulator equipped with sketchy 3-D modeling. Proc 
IEEE/ICME Int Conf Complex Med Eng. 293-296, 2005. 
 Isikawa C, Tsutamoto T, Wada A, Fujii M, Ohno K, Sakai H, Yamamoto T, Horie M: 
Inhibition of aldosterone and endothelin-1 by carperitide was attenuated more than one 
week Infusion in patients with congestive heart failure. J Cardiovasc Pharmacol. 46: 
513-518, 2005. 
 Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, Glembotski CC, Schaefer E, Beckerle M, 
Sussman MA: Atrial natriuretic peptide promotes cardiomyocyte survival by 
cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest. 115: 2716-2730, 
2005. 
 Makiyama T, Akao M, Tsuji K, Doi T, Ohno S, Takenaka K, Kobori A, Ninomiya T, 
Yoshida H, Takano T, Makita N, Yanagisawa F, Higashi Y, Takeyama Y, Kita T, Horie M: 
High-risk for bradyarrhythmic complications in patients with Brugada syndrome caused by 
SCN5A gene mutations. J Am Coll Cardiol. 46: 2100-2106, 2005. 
 Matsuo S, Nakamura I, Yamada T, Uchida I, Nakae I, Horie M: Effect of statin therapy on 
arterial stiffness in patients with hyperlipidemia: Shiga pravastatin atherosclerosis study 
(SHIPAS) group. J Appl Res. 5: 397-401, 2005. 
 Nakae I, Mitsunami K, Matsuo S, Inubushi T, Morikawa S, Tsutamoto T, Koh T, Horie M: 
Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H 
magnetic resonance spectroscopy. Circ J. 69: 711-716, 2005. 
 Nakae I, Mitsunami K, Matsuo S, Inubushi T, Morikawa S, Koh T, Horie M: Detection of 
calf muscle alterations in patients with chronic heart failure by 31P magnetic resonance 
spectroscopy: Impaired adaptation to continuous exercise. Exp Clin Cardiol. 10: 4-8, 2005. 
 Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M: Left ventricular systolic/diastolic 
function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography 
and plasma BNP analysis. Ann Nucl Med. 19: 447-454, 2005. 
 Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M: Clinical significance of plasma BNP 
measurement in patients with psychiatric disease. International Med J. 12: 181-184, 2005. 
 Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T, Tsujita Y, Horie M, 
Miki T, Ueshima H: Combined analysis of polymorphisms in angiotensinogen and adducin 
genes and their effect on hypertension in a Japanese population (The Shigaraki study). 
Hypertens Res. 28: 645-650, 2005. 
 Tanaka H, Hamamoto T, Takamatsu T: Toward an integrated understanding of the Purkinje 
fibers in the heart: the functional and morphological interconnection between the purkinje 
fibers and ventricular muscle. Acta Histochem Cytoc. 38: 257-265, 2005. 
 Tarutani Y, Matsumoto T, Takashima H, Yamane T, Horie M: Brachial artery flow-mediated 
vasodilation is correlated with coronary vasomotor and fibrinolytic responses induced by 
bradykinin. Hypertens Res. 28: 59-66, 2005. 
 Tsujita Y, Kato T, Sussman MA: Evaluation of left ventricular function in cardiomyopathic 
mice by tissue Doppler and color M-mode Doppler echocardiography. Echocardiography. 
22: 245-253, 2005. 
 Yao T, Ashihara T, Ito M, Nakazawa K, Horie M: Refractory gradient is responsible for the 
increase in ventricular vulnerability under sodium channel blockade. Circ J. 69: 345-353, 
2005. 
 Yasuda Y, Matuura H, Ito M, Matsumoto T, Ding W-G, Horie M: Regulation of the 
muscarinic K channel by extracellular ATP through membrane phosphatidylinositol 4, 
5-biphsopahte in guinea-pig atrial myocytes. Br J Pharmacol. 145: 156-165, 2005. 
 Zankov DP, Ding W-G, Matsuura H, Horie M: Open-state unblock characterizes acute 
inhibition of IKS potassium current by amiodarone in guinea-pig ventricular myocytes. J 
Cardiovasc Electrophysiol. 16: 314-322, 2005. 
 Zhang L, Benson DW, Tristani-Firouzi M, Ptacek LJ, Tawil R, Schwartz PJ, George AL, 
Horie M, Andelfinger G, Snow GL, Fu Y-Ackerman MJ, Vincent GM: 
Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 




 Ashihara T, Trayanova NA: Asymmetry in membrane responses to electric shocks: Insights 
from bidomain simulations. Biophys J. 87(4): 2271-2282, 2004. 
 Ashihara T, Namba T, Ito M, Ikeda T, Nakazawa K, Trayanova N: Spiral wave control by a 
localized stimulus: A bidomain model study. J Cardiovasc Electrophysiol. 15(2): 
226-233, 2004. 
 Ashihara T, Namba T, Ikeda T, Ito M, Nakazawa K, Trayanova N: Mechanisms of 
myocardial capture and temporal excitable gap during spiral wave reentry in a bidomain 
model. Circulation. 109(7): 920-925, 2004. 
 Ashihara T, Trayanova NA: Shock-induced changes in transmembrane potential: What is 
the asymmetry due to? Insights from bidomain simulations. Advances in 
Electrocardiology: World Scientific, Singapore, 2004, pp. 143-147. 
 Ashihara T, Trayanova NA: Mechanisms of shock-induced arrhythmogenesis: Role of 
tissue discontinuity and electroporation in the initiation of focal repetitive postshock 
activations. Advances in Electrocardiology: World Scientific, Singapore, 2004, pp. 
832-836. 
 Fujii M, Wada A, Ohnishi M, Tsutamoto T, Matsumoto T, Yamamoto T, Takayama T, 
Dohke T, Isono T, Eguchi Y, Horie M: Endogenous bradykinin suppresses myocardial 
fibrosis though the cardiac-genetated endothelin system under chronic 
angiotensin-converting enzyme inhibition in heart failure. J Cardiovasc Pharmacol. 
44(Suppl.1): S346-S349, 2004. 
 Kobori A, Sarai N, Shimizu W, Nakamura Y, Murakami Y, Makiyama T, Ohno S, Takenaka 
K, Ninomiya T, Fujiwara Y, Matsuoka S, Takano M, Noma A, Kita T, Horie M: Additional 
gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. 
J Cardiovasc Electrophysiol. 15: 1-10, 2004. 
 Matsumoto T, Takashima H, Ohira N, Tarutani Y, Yasuda Y, Yamane T, Matsuo S, Horie M: 
Plasma level of oxidized LDL is an independent determinant of coronary macro-and 
microvasomotor responses induced by bradykinin. J Am Coll Cardiol. 44: 451-457, 2004. 
 Matsuo S, Matsumoto T, Nakae I, Ito M, Nakamura Y, Takada M, Murata K, Horie M: 
Evaluation of cardiac resynchronization therapy in drug-resistant idiopathic dilated 
cardiomyopathy by means of technetium-99m tetrofosmin electrocardiography-gated 
single-photon emmision computed tomography. Exp Clin Cardiol. 9: 248-250, 2004. 
 Matsuo S, Matsumoto T, Takashima H, Ohira N, Yamane T, Yasuda Y, Tarutani Y, Horie M: 
The relationship between flow-mediated brachial artery vasodilation and coronary 
vasomotor responses to bradykinin: comparison with those to acetylcholine. J Cardiovasc 
Pharmacol. 44: 164-170, 2004. 
 Matsuo S, Nakamura Y, Matsumoto T, Nakae I, Nagatani H, Takazakura R, Takahashi M, 
Murata K, Horie M: Visual assessment of coronary artery stenosis with 
electrocardiographically-gated multislice computed tomography. Int J Cardiovasc 
Imaging. 20: 61-66, 2004. 
 Matsuo S, Matsumoto T, Nakae I, Koh T, Masuda D, Takada M, Murata K, Horie M: 
Prognostic value of ECG-gated thallium-201 single-photon emission tomography in 
patients with coronary artery disease. Ann Nucl Med. 18: 617-622, 2004. 
 Nakae I, Mitsunami K, Yabe T, Inubushi T, Morikawa S, Matsuo S, Koh T, Horie M: 
Detection of metabolic abnormality in asynergic regions of ischemic human myocardium 
using 31P and 1H magnetic resonance spectroscopy. J Cardiovasc Magn Reson. 6: 
685-696, 2004. 
 Nakae I, Mitsunami K, Matsuo S, Matsumoto T, Morikawa S, Inubushi T, Koh T, Horie M: 
Assessment of myocardial creatine concentration in dysfunctional human heart by proton 
magnetic resonance spectroscopy. Magn Reson Med Sci. 3: 19-25, 2004. 
 Nakamura Y, Tamaki S, Uchida Y, Ohmichi N, Yamaoka O, Miyauchi N, Fukuhara T, 
Sayama H, Yamada T, Matsuo S, Yamada Y: Angiotensin converting enzyme genotype 
influences the response to the angiotensin II receptor antagonist losartan in patients with 
hypertension. Hypertens Res. 27: 137-140, 2004. 
 Niimi A, Matsumoto H, Takemura M, Ueda T, Nakano Y, Mishima M: Clinical assessment 
of airway remodeling in asthma: utility of computed tomography. Clin Rev Allergy 
Immunol. 27: 45-58, 2004. 
 Ohira N, Matsumoto T, Tamaki S, Takashima H, Tarutani Y, Yamane T, Yasuda Y, Horie M: 
Angiotensin-converting enzyme insertion / deletion polymorphism modulates coronary 
release of tissue plasminogen activator in response to bradykinin. Hypertens Res. 27: 
39-45, 2004. 
 Ozawa T, Ito M, Tamaki S, Yao T, Ashihara T, Kita Y, Ueshima H, Horie M: Ventricular 
repolarization abnormality in Japanese carriers of G643S single nucleotide polymorphism 
of KCNQ1 gene. Advances in Electrocardiology: World Scientific, Singapore, 2004, pp. 
131-133. 
 Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, 
Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin J, Priori S, 
Kamakura S: Mutation site-specific differences in arrhythmic risk and sensitivity to 
sympathetic stimulaion in the LQT1 Form of congenital long QT syndrome. J Am Coll 
Cardiol. 44: 117-125, 2004. 
 Takayama T, Wada A, Tsutamoto T, Ohnishi M, Fujii M, Isono T, Horie M: Contribution of 
vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic 
effects of HMG-CoA reductase inhibitor. Circ J. 68: 1067-1075, 2004.  
 Tsutamoto T, Sakai H, Wada A, Ishikawa C, Ohno K, Fujii M, Yamamoto T, Takayama T, 
Dohke T, Horie M: Torasemide inhibits transcardiac extraction of aldosterone in patients 
with congestive heart failure. J Am Coll Cardiol. 44: 2252-2253, 2004. 
 Tsutamoto T, Wada A, Ohnishi M, Tsutsui T, Ishii C, Ohno K, Fujii M, Matsumoto T, 
Yamamoto T, Takayama T, Dohke T, Horie M: Transcardiac increase in tumor necrosis 
factor-alpha and left ventricular end-diastolic volume in patients with dilated 
cardiomyopathy. Eur J Heart Fail. 6: 173-180, 2004. 
 Yamamoto T, Wada A, Tsutamoto T, Ohnishi M, Horie M: Long-term treatment with a 
phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart 
failure through enhancing the natriuretic peptides-cGMP pathway. J Cardiovasc 
Pharmacol. 44: 596-600, 2004. 
 Yasumura Y, Miyatake K, Okamoto H, Miyauchi T, Kawana M, Tsutamoto T, Kitakaze M, 
Matsubara H, Takaoka H, Anzai T, Himeno H, Yokoyama H, Yokoya K, Shintani U, 
Hashimoto K, Koretsune Y, Nakamura Y, Imai K, Maruyama S, Masaoka Y, Sekiya M, 
Shiraki T, Shinohara H, Ozono K, Matsuoka T, Miyao Y, Nomura F: Rationale for the use 
of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor 
blocker therapy in heart failure. Circ J. 68: 361-366, 2004. 
 Yumoto Y, Horie M, Kubota T, Ninomiya T, Kobori A, Takenaka K, Takano M, Niwano S, 
Izumi T: Bepridil block of recombinant human cardiac IKs current shows a time-dependent 
unblock. J Cardiovasc Pharmacol. 43: 178-182, 2004. 
 
【２００３】 
 Ashihara T, Namba T, Yao T, Ozawa T, Kawase A, Ikeda T, Nakazawa K, Ito M: Vortex 
cordis as a mechanism of postshock activation: Arrhythmia induction study using a 
bidomain model. J Cardiovasc Electrophysiol. 14(3): 295-302, 2003. 
 Kawase A, Ikeda T, Nakazawa K, Ashihara T, Namba T, Kubota T, Sugi K, Hirai H: 
Widening of the excitable gap and enlargement of the core of reentry during atrial 
fibrillation with a pure sodium channel blocker in canine atria. Circulation. 107(6): 
905-910, 2003. 
 Hayahi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, Fujii M, Taniguchi A, 
Hamatani T, Nozato Y, Kataoka K, Morigami N, Ohnishi M, Kinoshita M, Horie M: 
Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents 
post-infarct left ventricular remodeling associated with suppression of a marker of 
myocardial collagen synthesis in patients with first anterior acute myocardial infarction. 
Circulation. 107: 2559-2565, 2003. 
 Horie M, Takenaka K, Ai T, Haruna T, Kono Y, Yoshida H, Kubota T, Ninomiya T, Kobori 
A, Ono S, Makiyama S, Otani and Takano M, Takaki H, Kamakura S, Shimizu W: 
Potassium Channels and Channelopathy-Clinical Cardiac Pacinc and 
Electrophysiology: Monduzzi Editore, 347-349, 2003. 
 Katsuta H, Ozawa S, Ninomiya T, Shimoyama T, Ito E, Tanaka T, Yamaguchi S, Katahira H, 
Nagamatsu S, Horie M, Ishida H: Insulinotropic action of glutamate is dependent on the 
inhibition of ATP-sensitive potassium channel activities in MIN6 beta cells. Biochem 
Biophys Res Commun. 311: 660-664, 2003. 
 Konishi H, Nishio S, Tsutamoto T, Minouchi T, Yamaji A: Serum carvediol concentation 
and its relation to change in plasma brain natriuretic peptide level in the treatment of heart 
failure: a preliminary study. Int J Clin Pharmol Ther. 41: 578-586, 2003. 
 Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, Takahashi N, Adachi Y, 
Takemura G, Horie M, Miyamoto Y, Morisaki T, Kuratomi S, Noma A, Fujiwara H, 
Yoshimasa Y, Kinoshita H, Kawakami R, Kishimoto I, Nakanishi M, Usami S, Saito Y, 
Harada M, Nakao K: NRSF regulates the fetal cardiac gene program and maintains normal 
cardiac structure and function. EMBO J. 22: 6310-6321, 2003. 
 Matsumoto T, Minai K, Horie H, Ohira N, Takashima H, Tarutani Y, Yasuda Y, Ozawa T, 
Matsuo S, Kinoshita M, Horie M: Angiotensin-converting enzyme inhibition but not 
angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen 
activator in hypertensive patients. J Am Coll Cardiol. 41(8): 1373-1379, 2003. 
 Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M: Chymase inhibition 
prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart 
failure. Circulation. 107(20): 2555-2558, 2003. 
 Matsuo S, Matsumoto T, Nakae I, Takashima H, Nakamura Y, Horie M: Non-invasive 
detection of endothelial dysfunction in femoral artery using thallium-201 scintigraphy. 
International Med J. 10: 39-42, 2003. 
 Matsuo S, Nakamura Y, Kinoshita M, Horie M: Plasma B-type natriuretic peptide 
measurement in asymptomatic population. International Med J. 10: 105-108, 2003. 
 Matsuo S, Nakamura Y, Matsumoto T, Nakae I, Murata K, Horie M: Prognostic value of 
iodine-123 metaiodobenzylguanidine imaging in patients with heart failure. Exp Clin 
Cardiol. 8: 95-98, 2003. 
 Nakae I, Matsumoto T, Omura T, Takashima H, Ohira N, Tarutani Y, Yasuda Y, Matsuo S, 
Koh T, Nakamura Y, Kinoshita M, Horie M: Endothelial modulation and tolerance 
development in the vasorelaxant responses to nitrate of rabbit aorta. Life Science. 73: 
3083-3094, 2003. 
 Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa 
S, Inubushi T, Nakamura Y, Kinoshita M, Horie M: Proton magnetic resonance 
spectroscopy can detect creatine depletion associated with the progression of heart failure 
in cardiomyopathy. J Am Coll Cardiol. 42: 1587-1593, 2003. 
 Ninomiya T, Takano M, Haruna T, Kono Y, Horie M: Verapamil, a Ca2+ entry blocker, 
targets the pore-forming subunit of cardiac type KATP channel (Kir6.2). J Cardiovasc 
Pharmacol. 42: 161-168, 2003. 
 Sekikawa A, Horiuchi BH, Edmundowicz D, Ueshima H, Curb DJ, Kim ST, Okamura T, 
Kadowaki T, Kashiwagi A, Mitsunami K, Nakamura Y, Murata K, Kuller LH, Okamura T: 
A "natural experiment" in cardiovascular epidemiology in the early-21st century. Heart. 
89: 255-257, 2003. 
 Takenaka K, Ai T, Shimizu W, Kobori A, Ninomiya T, Otani H, Kubota T, Takaki H, 
Kamakura S, Horie M: Exercise stress test amplifies genotype-phenotype correlation in the 
LQT1 and LQT2 forms of the long QT syndrome. Circulation. 107: 838-844, 2003. 
 Tsutamoto T, Tsutsui T, Maeda K, Hayashi M, Wada A, Ohnishi M, Fujii M, Ishii C: Effects 
of long-acting calcium channel antagonists on neurohumoral factors: comparison of 
nifedipine coat-core with amlodipine. J Cardiovasc Pharmacol. 41: 77-81, 2003. 
 Tsutamoto T, Wada A, Hayashi M, Tsutsui T, Maeda K, Ohnishi M, Sawaki M, Fujii M, 
Matsumoto T, Yamatoto T, Takayama T, Ishii C, Kinoshita M: Relationship between 
transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first 
anterior myocardial infarction. Eur Heart J. 24: 346-355, 2003. 
 Tsutamoto T, Wada A, Maeda K, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, 
Yamamoto T, Takayama T, Ishii C: Transcardiac gradient of aldosterone before and after 
spironolactone in patients with congestive heart failure. J Cardiovasc Pharmacol. 41: 
19-22, 2003. 
 
 
